Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers
- PMID: 12493175
- DOI: 10.1016/s0732-8893(02)00469-8
Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers
Abstract
As part of the Latin American arm of the SENTRY Antimicrobial Surveillance Program, 7,207 bacterial isolates collected consecutively from bloodstream infections (BSI) during the period of January 1997 through December 2000 were analyzed. Ten Latin American laboratories located in six countries participated in the study during each year. Antimicrobial susceptibility testing was performed using the reference NCCLS broth microdilution method. The most frequently isolated species were (n/%): Staphylococcus aureus (1,532/21.3%), Escherichia coli (1,239/17.2%), coagulase-negative Staphylococcus (1,002/13.9%), Klebsiella pneumoniae (664/9.2%), and Pseudomonas aeruginosa (470/6.5%). The prevalence of S. aureus as a cause of BSI increased from 20.5% in 1997 to 23.3% in 2000 (p = 0.011), but oxacillin-resistance rates remained relatively stable during this period (around 30%). Enterococci (216 isolates) showed low rates of resistance to both vancomycin (2.4%) and ampicillin (7.9%) and 72.7% of 289 Streptococcus pneumoniae isolates evaluated were susceptible to penicillin (MIC </=0.06 microg/mL). Resistance rates among Gram-negative bacilli were much higher than those reported in other regions evaluated in the SENTRY Program. The main antimicrobial resistance problems among these pathogens were the high prevalences of ESBL-producing E. coli (6.7%) and K. pneumoniae (47.3%), and carbapenem-resistance among P. aeruginosa (around 12%) and Acinetobacter spp. (around 10%). P. aeruginosa resistance rates to meropenem, piperacillin/tazobactam, amikacin, and ciprofloxacin showed a significant increase during the 4-year period evaluated. Resistance rates varied according to the country for several pathogen-antimicrobial combinations. In summary, resistance to most antimicrobial agents for a number of species implicated in bacteremia, especially among Gram-negative rods, has reached worrisome levels and continues to increase.
Similar articles
-
Skin and soft tissue infections in Latin American medical centers: four-year assessment of the pathogen frequency and antimicrobial susceptibility patterns.Diagn Microbiol Infect Dis. 2002 Nov;44(3):281-8. doi: 10.1016/s0732-8893(02)00468-6. Diagn Microbiol Infect Dis. 2002. PMID: 12493176
-
Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997-2000).Diagn Microbiol Infect Dis. 2002 Nov;44(3):301-11. doi: 10.1016/s0732-8893(02)00499-6. Diagn Microbiol Infect Dis. 2002. PMID: 12493178
-
Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002).Diagn Microbiol Infect Dis. 2004 Sep;50(1):59-69. doi: 10.1016/j.diagmicrobio.2004.05.003. Diagn Microbiol Infect Dis. 2004. PMID: 15380279
-
Literature review on the distribution characteristics and antimicrobial resistance of bacterial pathogens in neonatal sepsis.J Matern Fetal Neonatal Med. 2022 Mar;35(5):861-870. doi: 10.1080/14767058.2020.1732342. Epub 2020 Feb 26. J Matern Fetal Neonatal Med. 2022. PMID: 32102584 Review.
-
Prevalence of antimicrobial resistance and its clinical implications in Ethiopia: a systematic review.Antimicrob Resist Infect Control. 2021 Dec 3;10(1):168. doi: 10.1186/s13756-021-00965-0. Antimicrob Resist Infect Control. 2021. PMID: 34861894 Free PMC article.
Cited by
-
Isolation and Characterization of Novel Lytic Bacteriophages Infecting Carbapenem-Resistant Pathogenic Diarrheagenic and Uropathogenic Escherichia Coli.Infect Drug Resist. 2024 Aug 6;17:3367-3384. doi: 10.2147/IDR.S466101. eCollection 2024. Infect Drug Resist. 2024. PMID: 39135747 Free PMC article.
-
Molecular screening of virulence genes in extraintestinal pathogenic Escherichia coli isolated from human blood culture in Brazil.Biomed Res Int. 2014;2014:465054. doi: 10.1155/2014/465054. Epub 2014 Apr 15. Biomed Res Int. 2014. PMID: 24822211 Free PMC article.
-
Phylogeny and antimicrobial resistance of extended-spectrum beta-lactamaseproducing Escherichia coli from hospitalized oncology patients in Perú.Biomedica. 2022 Sep 2;42(3):470-478. doi: 10.7705/biomedica.6263. Biomedica. 2022. PMID: 36122287 Free PMC article. English, Spanish.
-
Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013-2015).Braz J Infect Dis. 2017 Nov-Dec;21(6):627-637. doi: 10.1016/j.bjid.2017.06.008. Epub 2017 Sep 21. Braz J Infect Dis. 2017. PMID: 28941394 Free PMC article.
-
The impact of production of extended-spectrum β-lactamases on the 28-day mortality rate of patients with Proteus mirabilis bacteremia in Korea.BMC Infect Dis. 2017 May 3;17(1):327. doi: 10.1186/s12879-017-2431-8. BMC Infect Dis. 2017. PMID: 28468622 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous